| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hologic Inc (HOLX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. HOLX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.42M | $108.23M | - | |
| Other | 17.9K | $1.36M | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - | |
| Other | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2017 | Ullian Elaine | Director | Sale+OE | 8,849 | $45.28 | $400,673.87 | -27.1% | |
| Jun 7, 2017 | Levy Lawrence M | Director | Sale+OE | 2,960 | $44.54 | $131,838.40 | -6.5% | |
| Jun 2, 2017 | Ullian Elaine | Director | Sale+OE | 8,938 | $43.99 | $393,182.62 | -27.3% | |
| May 31, 2017 | Levy Lawrence M | Director | Sale+OE | 9,146 | $43.27 | $395,719.98 | -18.7% | |
| May 30, 2017 | Valenti Peter J. III | Division Pres., Breast Health | Sale+OE | 10,005 | $43.44 | $434,634.95 | -27.4% | |
| May 24, 2017 | Levy Lawrence M | Director | Sale+OE | 9,193 | $42.93 | $394,655.49 | -19.9% | |
| May 17, 2017 | Levy Lawrence M | Director | Sale+OE | 9,076 | $42.80 | $388,470.04 | -21.0% | |
| May 10, 2017 | Levy Lawrence M | Director | Sale+OE | 9,837 | $45.34 | $445,974.70 | -13.6% | |
| May 3, 2017 | Ullian Elaine | Director | Sale+OE | 8,856 | $45.09 | $399,317.04 | -27.1% | |
| May 3, 2017 | Levy Lawrence M | Director | Sale+OE | 10,203 | $45.00 | $459,135.56 | -14.8% |